1. Home
  2. RCI vs RPRX Comparison

RCI vs RPRX Comparison

Compare RCI & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCI
  • RPRX
  • Stock Information
  • Founded
  • RCI 1960
  • RPRX 1996
  • Country
  • RCI Canada
  • RPRX United States
  • Employees
  • RCI N/A
  • RPRX N/A
  • Industry
  • RCI Cable & Other Pay Television Services
  • RPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCI Telecommunications
  • RPRX Health Care
  • Exchange
  • RCI Nasdaq
  • RPRX Nasdaq
  • Market Cap
  • RCI 21.1B
  • RPRX 16.2B
  • IPO Year
  • RCI N/A
  • RPRX 2020
  • Fundamental
  • Price
  • RCI $38.26
  • RPRX $39.23
  • Analyst Decision
  • RCI Hold
  • RPRX Strong Buy
  • Analyst Count
  • RCI 2
  • RPRX 3
  • Target Price
  • RCI $34.50
  • RPRX $46.00
  • AVG Volume (30 Days)
  • RCI 1.1M
  • RPRX 3.9M
  • Earning Date
  • RCI 10-23-2025
  • RPRX 11-05-2025
  • Dividend Yield
  • RCI 3.72%
  • RPRX 2.25%
  • EPS Growth
  • RCI 341.45
  • RPRX N/A
  • EPS
  • RCI 8.96
  • RPRX 1.75
  • Revenue
  • RCI $15,091,643,989.00
  • RPRX $2,349,844,000.00
  • Revenue This Year
  • RCI $7.45
  • RPRX $36.16
  • Revenue Next Year
  • RCI $5.57
  • RPRX $2.04
  • P/E Ratio
  • RCI $4.29
  • RPRX $22.36
  • Revenue Growth
  • RCI 2.75
  • RPRX 3.70
  • 52 Week Low
  • RCI $23.18
  • RPRX $24.05
  • 52 Week High
  • RCI $40.26
  • RPRX $41.24
  • Technical
  • Relative Strength Index (RSI)
  • RCI 56.61
  • RPRX 59.26
  • Support Level
  • RCI $36.60
  • RPRX $38.39
  • Resistance Level
  • RCI $38.44
  • RPRX $40.01
  • Average True Range (ATR)
  • RCI 0.68
  • RPRX 1.26
  • MACD
  • RCI -0.12
  • RPRX 0.12
  • Stochastic Oscillator
  • RCI 47.68
  • RPRX 63.19

About RCI Rogers Communication Inc.

Rogers Communications is the largest wireless service provider in Canada with more than 11 million subscribers, equating to one-third of the total Canadian market. Rogers' wireless business accounts for more than half of total revenue and has been growing at a higher rate than other segments. The cable segment, which provides about 38% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and the Toronto Blue Jays. Rogers' significant exposure to sports also includes ownership stakes in the Maple Leafs, Raptors, Toronto FC, and Argonauts.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: